“By Friday, we should have an answer as to where we’re going with it. I would think that we’re not going to go beyond Friday in the extension of this pause,” Fauci, the longtime head of the National Institute of Allergy and Infectious Diseases, said.
“I don’t want to get ahead of them. But I don’t think that they’re going to completely cancel because the data, or such, at least from what we see, they’re looking to see if there are more cases,” he added.
WATCH: BRITISH COLONEL RICHARD KEMP REPORTING FROM GAZA
Federal health officials on April 13 suggested states stop giving Johnson & Johnson shots because six women who had received a shot developed a rare type of blood clot called cerebral venous sinus thrombosis in conjunction with low blood platelet levels. One of the women passed away.
TRUMP READY TO DEBATE BIDEN 'ANYWHERE, ANYTIME, ANYPLACE,' BUT WILL IT HAPPEN?
Joining the concerns is the connection between Johnson & Johnson’s vaccine and one produced by the UK’s AstraZeneca, which has been associated with at least 169 post-vaccination blood clot cases in Europe and was found to be “likely linked” to a death in Australia.
WATCH: NO CLUE WHY THEY ARE PROTESTING: "I WISH I WAS MORE EDUCATED"
States across the nation took heed of the federal advice, stopping the use of the vaccine.
CRITICS SLAM BIDEN'S ATTEMPT TO RELATE PERSONAL TRAGEDY TO POLICE OFFICER DEATHS
The pause was directed at planning health care workers “to recognize and treat patients appropriately, and to report severe events they may be seeing in people who’ve received the J&J vaccine,” Dr. Anne Schuchat, principal deputy director of the Centers for Disease Control and Prevention (CDC), told reporters in a call last week.
FROM DISGRACE TO REDEMPTION: DAN RATHER TO MAKE UNEXPECTED RETURN TO CBS
One urgent notice to spread is that the conventional treatment for clots, the anticoagulant Heparin, could actually make things worse for the patients in question due to the type of clot.
The build-up in the number of cases urged officials at the CDC and the Food and Drug Administration (FDA), which are investigating each case, to recommend a halt, Fauci said on Sunday, adding that the agencies could end up recommending, based on the data they find, that some populations should not get the Johnson & Johnson shot.
KARMA IS A B*TCH: COUNCIL MEMBERS WHO CRITICIZED NYPD NOW BEGGING FOR THEIR PROTECTION
“We did not have enough information to make a narrow restriction off the bat. When we get more information and that’s what we’re talking about Friday, it may be by the time you get to Friday that they will say, ‘OK, we’ve looked into it now. Here are some of the restrictions.’ But I think it would have been too early to have restrictions without looking more closely at it,” he said.
Discover alternative ideas that will make you think
Engage in mind bending debate
Earn points, rise in rank, have fun
